BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1396726)

  • 1. Cotrimoxazole therapy of Toxoplasma gondii encephalitis in AIDS patients.
    Canessa A; Del Bono V; De Leo P; Piersantelli N; Terragna A
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):125-30. PubMed ID: 1396726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections.
    Li Y; Zeng YM; Lu YQ; Qin YY; Chen YK
    Medicine (Baltimore); 2020 May; 99(20):e20146. PubMed ID: 32443329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Antinori A; Murri R; Ammassari A; De Luca A; Linzalone A; Cingolani A; Damiano F; Maiuro G; Vecchiet J; Scoppettuolo G
    AIDS; 1995 Dec; 9(12):1343-50. PubMed ID: 8605054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cerebral toxoplasmosis in AIDS: efficacy and good tolerance of cotrimoxazole].
    Smadja D; Lin L; Cidolit E; Neisson-Vernant C; Cabre P; Vernant JC
    Presse Med; 1994 May; 23(19):907. PubMed ID: 7937621
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.
    Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS.
    Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA
    Ann Intern Med; 1992 Jul; 117(2):106-11. PubMed ID: 1351371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study about the use of cotrimoxazole as diagnostic support and treatment of suspected cerebral toxoplasmosis in AIDS.
    Solbreux P; Sonnet J; Zech F
    Acta Clin Belg; 1990; 45(2):85-96. PubMed ID: 2164314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic sulfonamides plus clindamycin as an alternative therapeutic regimen for HIV-associated Toxoplasma encephalitis: a randomized controlled trial.
    Li Y; Zeng Y; Lu Y; He X; Wu Y; Zhang W; Huang Y; Chen H; Chen Y
    Chin Med J (Engl); 2022 Nov; 135(22):2718-2724. PubMed ID: 36574221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting.
    Goswami RP; Goswami RP; Rahman M; Ray Y; Tripathi SK
    Int J STD AIDS; 2015 Oct; 26(12):864-9. PubMed ID: 25411350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of folinic acid in cytopenia induced by antiparasitic drugs in AIDS patients].
    Niyongabo T; Leport C; Vildé JL
    Presse Med; 1991 Oct; 20(34):1677-81. PubMed ID: 1836573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option?
    Hernandez AV; Thota P; Pellegrino D; Pasupuleti V; Benites-Zapata VA; Deshpande A; Penalva de Oliveira AC; Vidal JE
    HIV Med; 2017 Feb; 18(2):115-124. PubMed ID: 27353303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of cerebral toxoplasmosis in AIDS with cotrimoxazole].
    Finielz P; Chuet C; Ramdane M; Guiserix J
    Presse Med; 1995 May; 24(19):917. PubMed ID: 7638140
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group.
    Dannemann B; McCutchan JA; Israelski D; Antoniskis D; Leport C; Luft B; Nussbaum J; Clumeck N; Morlat P; Chiu J
    Ann Intern Med; 1992 Jan; 116(1):33-43. PubMed ID: 1727093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of alternative treatment approach for cerebral toxoplasmosis among HIV/AIDS patients from a resource-poor setting in Burkina Faso.
    Bamba S; Zoungrana J; Nikièma Z; Sondo AK; Ndiaye JL; Bretagne S
    Ann Parasitol; 2017; 63(3):173–181. PubMed ID: 29274210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse cutaneous reactions to pyrimethamine/sulfadiazine and pyrimethamine/clindamycin in patients with AIDS and toxoplasmic encephalitis.
    Caumes E; Bocquet H; Guermonprez G; Rogeaux O; Bricaire F; Katlama C; Gentilini M
    Clin Infect Dis; 1995 Sep; 21(3):656-8. PubMed ID: 8527561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group.
    Torre D; Casari S; Speranza F; Donisi A; Gregis G; Poggio A; Ranieri S; Orani A; Angarano G; Chiodo F; Fiori G; Carosi G
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1346-9. PubMed ID: 9624473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
    Katlama C; Mouthon B; Gourdon D; Lapierre D; Rousseau F
    AIDS; 1996 Sep; 10(10):1107-12. PubMed ID: 8874627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome.
    Cohn JA; McMeeking A; Cohen W; Jacobs J; Holzman RS
    Am J Med; 1989 May; 86(5):521-7. PubMed ID: 2712059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clindamycin for toxoplasma encephalitis in AIDS.
    Remington JS; Vildé JL
    Lancet; 1991 Nov; 338(8775):1142-3. PubMed ID: 1682559
    [No Abstract]   [Full Text] [Related]  

  • 20. Cotrimoxazole for treatment of cerebral toxoplasmosis: an observational cohort study during 1994-2006.
    Béraud G; Pierre-François S; Foltzer A; Abel S; Liautaud B; Smadja D; Cabié A
    Am J Trop Med Hyg; 2009 Apr; 80(4):583-7. PubMed ID: 19346380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.